United States · FDA National Drug Code directory
Ganciclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-315_e51e0b68-6b11-42f5-82a2-87c480cb5c41
- Product NDC
- 63323-315
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- GANCICLOVIR SODIUM
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100628
- Source listing expiry
- 20271231
Source-listed ingredients
- GANCICLOVIR SODIUM — 500 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 TRAY (63323-315-94) / 10 mL in 1 VIAL (63323-315-41) · 63323-315-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →